Executive Director, Oncology DD & Commercialization Communications
Bristol Myers Squibb
Summary
The Executive Director, Oncology Drug Development & Commercialization Communications in Corporate Affairs, is responsible for the overall strategy, execution, and measurement of product, pipeline, and therapeutic area communications across BMS's oncology portfolio — spanning both Drug Development and Commercialization. This includes marketed brands, late-stage pipeline assets, new indications, and therapeutic areas including solid tumors, hematologic malignancies, and cell therapy modalities.
Job description
Role
The Executive Director, Oncology Drug Development & Commercialization Communications in Corporate Affairs, is responsible for the overall strategy, execution, and measurement of product, pipeline, and therapeutic area communications across BMS's oncology portfolio — spanning both Drug Development and Commercialization. This includes marketed brands, late-stage pipeline assets, new indications, and therapeutic areas including solid tumors, hematologic malignancies, and cell therapy modalities.
Leading a team of communications professionals, the Executive Director will serve as the primary Corporate Affairs advisor to senior leaders across both the Global Drug Development and Oncology Commercialization organizations, as well as their associated leadership teams. This role will partner closely with commercial, medical, regulatory, legal, and development functions, and operate within and across the Corporate Affairs matrix to drive integrated internal and external communications at every stage of the product lifecycle.
The Executive Director will also lead internal communications to engage and inspire employees across oncology and will develop thought leadership programs for senior executives in both the development and commercialization organizations. This leader will guide above-brand oncology communications strategy, reputational issues management, and risk mitigation globally and in the U.S., with the overarching goal of elevating BMS's position as a leader in oncology and cancer care.
Responsibilities
Integrated Communications Strategy
- Lead global internal and external communications strategy and execution across BMS's oncology portfolio, spanning marketed brands, new indications, late-stage assets, business development activity, and key therapeutic areas.
- Create above-brand campaigns and messaging that strengthen understanding of unmet patient needs and confidence in BMS's oncology strategy and pipeline.
Thought Leadership & Executive Visibility
- Strengthen BMS's oncology reputation through integrated thought leadership, media, speaking, social, and digital programs.
- Develop measurable visibility plans for senior Drug Development and Commercialization leaders, aligned with Corporate Affairs priorities.
- Partner across commercial, medical, and development teams to advance a consistent BMS oncology narrative across audiences and channels.
Milestone & Pipeline Communications
- Lead communications for data, regulatory, and medical meeting milestones across the oncology portfolio, including media, digital, employee, and market activation.
- Advise senior Drug Development and Commercialization leaders and represent Corporate Affairs on relevant leadership teams.
Cross-Functional Partnership
- Represent Corporate Affairs in cross-functional and worldwide brand forums, shaping scenarios, messages, stakeholder engagement, and brand initiatives.
- Build integrated brand communications strategies with Corporate Communications, R&D Communications, Patient Advocacy, Access, Pricing and Policy, GPS Communications, and other partners.
- Provide communications counsel on manufacturing matters and identify proof points that reinforce confidence in BMS's capabilities.
Issues Management & Reputation
- Lead global oncology issues management, aligning portfolio-, brand-, and event-specific messaging across U.S. and international markets to mitigate risk and protect BMS's reputation.
Digital, Social & Editorial
- Lead the oncology editorial, social, and digital plan in support of business priorities and enterprise channel strategy.
- Build awareness of BMS oncology therapies through milestone communications, educational content, branded PR, campaigns, earned media, and appropriate patient, HCP, and advocacy voices.
Global Markets
- Align global and market communications, providing plans and content early enough for effective local adaptation and execution.
People & Operations
- Lead, coach, and develop the oncology communications team; clarify priorities, strengthen capabilities, and optimize resources and service models.
- Manage budgets, contracts, and agency partners to deliver strong performance and financial stewardship.
- Establish measurement practices to optimize performance and demonstrate impact against objectives.
Requirements
- 15+ years of experience in brand or corporate communications in the pharmaceutical industry
- Demonstrated track record of setting and delivering against integrated global communications strategies
- Expertise in strategic planning, issues management, internal communications, executive and thought leadership communications, social and digital media, and product communications across the product lifecycle
- Bachelor's degree required, ideally in communications or a related field
- Master's degree preferred
- Pharmaceutical or healthcare experience required
- Oncology, hematology, cell therapy, or autoimmune experience preferred
- Proven ability to drive successful brand and therapeutic area communications strategy in close coordination with commercial and development business partners
- Exceptional collaboration skills
- Demonstrated ability to advise and influence senior leadership
- Strong science acumen and understanding of regulatory policy, R&D, pricing, and access
- Strong problem-solving, management, and leadership skills
- Direct experience leading teams of communications professionals
- Superior written and interpersonal communication skills
- Strong presentation and facilitation skills
- Deep knowledge of stakeholder engagement, content creation, channel strategy, and digital and social media best practices
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- Retirement Benefits
- Flexible Time Off
- Paid Holidays
- Volunteer Days
- Global Shutdown
Company overview
Bristol Myers Squibb is a global biopharmaceutical company dedicated to discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases. Founded in 1887 and headquartered in Princeton, New Jersey, the company operates with a unique BioPharma strategy that combines the reach and resources of a major pharmaceutical company with the entrepreneurial spirit and agility of a biotech firm. BMS focuses on transformative therapies in key therapeutic areas including oncology, hematology, immunology, cardiovascular disease, and fibrosis. The company has built a sustainable pipeline of potential therapies and leverages translational medicine and data analytics to deliver the right medicine to the right patient at the right time. With over 10,000 employees worldwide, Bristol Myers Squibb maintains a strong commitment to scientific excellence, patient-centric innovation, and global health equity through its foundation. The company's portfolio includes groundbreaking treatments such as Opdivo (nivolumab) for cancer, Eliquis (apixaban) for cardiovascular conditions, and Orencia (abatacept) for autoimmune diseases, among others.